Blockade of oral tolerance to ovalbumin in mice by silver nanoparticles

Papers of special note have been highlighted as: • of interest

References

• 1 Chaloupka K, Malam Y, Seifalian AM. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol. 28(11), 580–588 (2010).
  Medline CASGoogle Scholar
• 2 Benn TM, Westerhoff P. Nanoparticle silver released into water from commercially available sock fabrics. Environ. Sci. Technol. 42(11), 4133–4139 (2008).
  Medline CASGoogle Scholar
• 3 Chaudhry Q, Scotter M, Blackburn J et al. Applications and implications of nanotechnologies for the food sector. Food Addit. Contam. Part A 25(3), 241–258 (2008).
  Medline CASGoogle Scholar
• 4 Park E-J, Bae E, Yi J et al. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ. Toxicol. Pharmacol. 30(2), 162–168 (2010).
  Medline CASGoogle Scholar
• 5 Kim YS, Song MY, Park JD et al. Subchronic oral toxicity of silver nanoparticles.. Part. Fibre Toxicol. 7, 20–30 (2010).
  MedlineGoogle Scholar
• 6 Loeschner K, Hadrup N, Qvortrup K et al. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part. Fibre Toxicol. 8, 18–31 (2011).
  Medline CASGoogle Scholar
• 7 van der Zande M, Vandebriel RJ, Doren EV et al. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 6(8), 7427–7442 (2012).
  Medline CASGoogle Scholar
• 8 Garside P, Mowat A, Khoruts A. Oral tolerance in diseases. Gut 44(1), 137–142 (1999).
  Medline CASGoogle Scholar
• 9 Faria AMC, Weiner HL. Oral tolerance. Immunol. Rev. 206, 232–259 (2005).• Most thorough review on oral tolerance.
  Medline CASGoogle Scholar
• 10 Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3(4), 331–341 (2003).
  Medline CASGoogle Scholar
• 11 Khramova DS, Popov SV, Golovchenko VV, Vityazev FV, Paderin NM, Ovodov YS. Abrogation of the oral tolerance to in mice by citrus pectin. Nutrition 25(2), 226–232 (2009).
  Medline CASGoogle Scholar
• 12 Yoshino S, Ohsawa M, Sagai M. Diesel exhaust particles block induction of oral tolerance in mice. J. Pharmacol. Exp. Ther. 287(2), 679–683 (1998).• One of the first reports on the effect of particles on the induction of oral tolerance.
  Medline CASGoogle Scholar
• 13 Matsumura M, Takasu N, Nagata M, Nakamura K, Kawai M, Yoshino S. Effect of ultrafine zinc oxide (ZnO) nanoparticles on induction of oral tolerance in mice. J. Immunotoxicol. 7(3), 232–237 (2010).• First report on the effect of nanoparticles on the induction of oral tolerance.
  Medline CASGoogle Scholar
• 14 Kittler S, Greulich C, Diendorf J, Koller M, Epple M. Toxicity of silver nanoparticles increases during storage because of slow dissolution under release of silver ions. Chem. Mater. 22(16), 4548–4554 (2010).
  CASGoogle Scholar
• 15 Navarro E, Piccapietra F, Wagner B et al. Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Environ. Sci. Technol. 42(23), 8959–8964 (2008).
  Medline CASGoogle Scholar
• 16 Cheng Y, Yin L, Lin S, Wiesner M, Bernhardt E, Liu J. Toxicity reduction of polymer-stabilized silver nanoparticles by sunlight. J. Phys. Chem. C 115(11), 4425–4432 (2011).
  CASGoogle Scholar
• 17 Kennedy AJ, Hull MS, Bednar AJ et al. Fractionating nanosilver: importance for determining toxicity to aquatic test organisms. Environ. Sci. Technol. 44(24), 9571–9577 (2010).
  Medline CASGoogle Scholar
• 18 Oliveira FM, Santos EM, Mota-Santos TA, Ruiz-De-Souza V, Gontijo CM. Covalent coupling of palmitate to inhibits and blocks the induction of oral tolerance. Scand. J. Immunol. 55(6), 570–576 (2002).
  Medline CASGoogle Scholar
• 19 Chen X-X, Cheng B, Yang Y-X et al. Characterization and preliminary toxicity assay of nano-titanium dioxide additive in sugar-coated chewing gum. Small 9(9–10), 1765–1774 (2013).
  Medline CASGoogle Scholar
• 20 Xu YY, Tang H, Liu J-H, Wang HF, Liu YF. Evaluation of the adjuvant effect of silver nanoparticles both in vitro and in vivo. Toxicol. Lett. 219(1), 42–48 (2013).
  Medline CASGoogle Scholar
• 21 Li BW, Rush A, Zhang SR, Curtis KC, Weil GJ. Antibody responses to Brugia malayi antigens induced by DNA vaccination. Filarial J. 3, 1–8 (2004).
  MedlineGoogle Scholar
• 22 Kim T, Lee CH, Joo SW, Lee K. Kinetics of gold nanoparticle aggregation: experiments and modeling. J. Colloid. Interface Sci. 318(2), 238–243 (2008).
  Medline CASGoogle Scholar
• 23 Xiu Z-M, Zhang QB, Puppala HL, Colvin VL, Alvarez PJJ. Negligible particle-specific antibacterial activity of silver nanoparticles. Nano Lett. 12(8), 4271–4275 (2012).• First definitive statement claimed that the antibacterial activity of silver nanoparticles was solely due to the released ions.
  Medline CASGoogle Scholar
• 24 Böhmert L, Niemann B, Thünemann AF, Lampen A. Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2. Arch. Toxicol. 86(7), 1107–1115 (2012).
  MedlineGoogle Scholar
• 25 Hadrup N, Lam HR, Loeschner K, Mortensen A, Larsen EH, Frandsen H. Nanoparticulate silver increases uric acid and allantoin excretion in rats, as identified by metabolomics. J. Appl. Toxicol. 32(11), 929–933 (2012).
  Medline CASGoogle Scholar
• 26 Walczak AP, Fokkink R, Peters R et al. Behaviour of silver nanoparticles and silver ions in an in vitro human gastrointestinal digestion model. Nanotoxicology 7(7), 1198–1210 (2013).
  Medline CASGoogle Scholar
• 27 Walkey CD, Chan WCW. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem. Soc. Rev. 41(7), 2780–2799 (2012).
  Medline CASGoogle Scholar
• 28 Weiner HL. Oral tolerance, an active immunologic process mediated by multiple mechanisms. J. Clin. Invest. 106(8), 935–937 (2000).
  Medline CASGoogle Scholar
• 29 Inobe J, Slavin AJ, Komagata Y, Chen Y, Liu L, Weiner HL. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol. 28(9), 2780–2790 (1998).
  Medline CASGoogle Scholar
• 30 Slavin AJ, Maron R, Weiner HL. Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes. Int. Immunol. 13(6), 825–833 (2001).
  Medline CASGoogle Scholar
• 31 Khoury SJ, Lider O, Al-Sabbagh A, Weiner HL. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lypopolysaccharide. Cell. Immunol. 131(2), 302–310 (1990).
  Medline CASGoogle Scholar
• 32 Yang E-J, Kim S, Kim JS, Choi I-H. Inflammasome formation and IL-1β release by human blood monocytes in response to silver nanoparticles. Biomaterials 33(28), 6858–6867 (2012).
  Medline CASGoogle Scholar